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Background and Recent
Developments
As a general principle, the concentration of
humans or animals in proximity enhances
potential transmission of microorganisms
among members of the group. It also creates
greater potential for infecting surrounding life
forms, even those of different species. The
conditions created also may be a breeding
ground for new, more infectious, or more
resistant microorganisms. 
As the human population increases, and
mega cities grow, there is greater risk that
infectious diseases will evolve, emerge, or
spread readily among the populace. The
increasing food needs of the growing human
population likely will lead to greater popula-
tions of livestock. The concentration of ani-
mals may augment the risk of zoonoses,
diseases transmissible from animals to
humans. All segments of livestock production
might potentially contribute to zoonotic dis-
ease, including transportation of livestock,
manure handling practices, veterinary medi-
cine, meat processing and animal rendering.
Ideally, everyone involved in each of these
components of the industry should be cog-
nizant of the infectious disease risks to ani-
mals and humans alike.
Among the many examples of existing
risks, some of the more recent are highly per-
tinent. Nipah virus infections, which
occurred in concentrated swine herds in
Malaysia and Singapore, killed swine and
swine workers (Chua et al. 1999; Paton et al.
1999). Avian influenza has recently infected
and caused deaths among poultry and poultry
workers in Asia, South America, North
America, and Europe [Centers for Disease
Control and Prevention 2005; World Health
Organization (WHO) 2004]. Many zoonoses
may not be related solely to concentrated ani-
mal husbandry, but this workshop was
devoted to those at least partially attributable
to concentration and practices associated with
them. While there are many known potential
risks for human infection that may result
from high concentrations of animals, this
article will focus on two—influenza and
antibiotic resistance. In addition, we briefly
discuss the means of transmission or propaga-
tion of infectious agents, including water,
animal feed, and human food.
Antibiotic resistance. State of science.
Antibiotic resistance is increasing among most
human pathogens. The many bacteria resis-
tant to multiple antibiotics in particular has
heightened concern. In some cases there are
few or no antibiotics available to treat resistant
pathogens [Institute of Medicine (IOM)
1998; Mølbak et al. 1999]. Development of
new antibiotic classes has lagged behind phar-
maceutical innovation in other areas, and
some innovative new approaches to combat-
ing infection are still immature and unproven
(Infectious Diseases Society of America 2005;
IOM 1998). Escalating resistance has raised
concern that we are entering the “post antibi-
otic era,” meaning we may be entering a
period where there would be no effective
antibiotics available for treating many life-
threatening infections in humans. If this
proves true, deaths due to infection will once
again become a very real threat to substantial
numbers of children and young adults as well
as the sick and the elderly.
Increased antibiotic resistance can be
traced to the use and overuse of antibiotics.
Much of that use occurs in human medicine.
Health care policy and practice changes
designed to minimize this phenomenon are
in place in many countries, yet much more
can be done. Although antibiotic overuse in
animals is problematic, the magnitude of the
problem is unknown. There is no national
mechanism for collecting data on antibiotic
use in many countries and the pharmaceutical
industry treats production and sales ﬁgures as
conﬁdential business information. However,
the Union of Concerned Scientists (2001)
has estimated that 11.2 million kg of the
antibiotics used annually in the United States
are administered to livestock as growth pro-
moters. This compares with their estimate of
1.4 million kg for human medical use. Their
estimates indicate that 87% of all antibiotic
use is for animals, while 13% is for human
therapeutic and nontherapeutic use. One
researcher suggests lower ﬁgures for antibiotic
use in growth promotion, stating that no
more than 40% of antibiotics in the United
States is for animals (Levy 1998). As the
IOM recently concluded, 
Clearly, a decrease in antimicrobial use in human
medicine alone will have little effect on the cur-
rent situation. Substantial efforts must be made to
decrease inappropriate overuse in animals and
agriculture as well. [National Academy of Sciences
(NAS) 2003] 
Therapeutic antibiotic administration at
high levels for the duration of an illness is
obviously an important aspect of veterinary
care. However, most animal antibiotic use is
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The industrialization of livestock production and the widespread use of nontherapeutic antimicrobial
growth promotants has intensiﬁed the risk for the emergence of new, more virulent, or more resis-
tant microorganisms. These have reduced the effectiveness of several classes of antibiotics for treating
infections in humans and livestock. Recent outbreaks of virulent strains of inﬂuenza have arisen from
swine and poultry raised in close proximity. This working group, which was part of the Conference
on Environmental Health Impacts of Concentrated Animal Feeding Operations: Anticipating
Hazards—Searching for Solutions, considered the state of the science around these issues and con-
curred with the World Health Organization call for a phasing-out of the use of antimicrobial growth
promotants for livestock and ﬁsh production. We also agree that all therapeutic antimicrobial agents
should be available only by prescription for human and veterinary use. Concern about the risk of an
inﬂuenza pandemic leads us to recommend that regulations be promulgated to restrict the co-loca-
tion of swine and poultry concentrated animal feeding operations (CAFOs) on the same site and to
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feed conversion ratio. However, the growth
rate gains with antibiotic growth promotants
are less signiﬁcant with currently used breeds
of swine and poultry (Wegener 2003). This
prolonged use of antibiotics, especially at low
levels, presents a risk of not killing the
bacteria while promoting their resistance by
selecting for resistant populations. The resis-
tance genes can pass readily from one kind of
bacteria to another (Levy 1998). Thus, workers
in the animal units may become colonized
with resistant organisms and can pass them on
to co-workers and family members or friends.
Consumers of meat may also become colo-
nized through mishandling of raw meat or
through insufﬁcient cooking. Ultimately, these
genes may pass into pathogens, and diseases
that were formerly treatable will be capable of
causing severe illness or death (NAS 2003). 
Evidence of resistance associated with
antimicrobial growth promotants has been
emerging over the past three decades.
Tetracycline-resistant organisms were found
in 1976 in chickens raised on feed supple-
mented with tetracycline, a human-use anti-
biotic. In a prospective study of 11 poultry
farm members and 24 neighbors, Levy and
co-workers (1976a) found that before the use
of tetracycline on the farm neither the farmers
nor the animals were positive for tetracycline-
resistant intestinal ﬂora. Within 5 months of
the introduction of tetracycline in the poultry
feed, 31.3% of fecal samples from farm mem-
bers harbored intestinal ﬂora that were resis-
tant to tetracycline even though none had
been treated clinically with tetracycline.
Tetracycline-resistant bacteria were found in
only 6.8% of the samples from neighbors.
Vancomycin-resistant enterococci arose in
livestock in Europe in the 1970s because of
use of Avoparcin as an antibiotic growth pro-
motant. Neither Avoparcin nor vancomycin
was approved for use in livestock in the
United States, and vancomycin-resistant
enterococci did not emerge in U.S. livestock
(Levy et al. 1976b). White and co-workers
purchased 200 samples of ground meat in the
Washington, DC, area and found that 20%
contained culturable Salmonella. Of these,
84% of the organisms were resistant to at
least one antibiotic tested, and 53% were
resistant to three or more (White et al. 2001).
Tetracycline resistance genes were identified
in a swine CAFO and also in the manure
lagoon serving that CAFO and in ground-
water 250 m downstream of the lagoon
(Chee-Sanford et al. 2001). Using a med-
icated feed containing tylosin (a macrolide
antibiotic), Zahn et al. (2001) compared
swine CAFOs with CAFOs using a nonmed-
icated feed and observed a 3-fold higher con-
centration of tylosin-resistant bacteria in the
exhaust air from the CAFOs. Antibiotics have
also been measured in the dust from swine
CAFOs (Hamscher et al. 2003).
Several recent studies clearly demonstrate
the transmission of multidrug-resistant
pathogens from swine to humans. A French
group studied 44 nasal Staphylococcus aureus
isolates from healthy pig farmers and
21 healthy controls. Five isolates were found in
pig farmers that were methicillin resistant.
Other isolates were resistant to penicillin, lin-
comycin, erythromycin, pristinamycin,
kanamycin, peﬂoxacin (Armand-Lefevre et al.
2005). By comparing these findings with
analyses of isolates from swine infections, the
authors concluded that transmission of these
resistant organisms from swine to pig farmers
may be frequent. Voss and co-workers (2005)
in the Netherlands studied methicillin-resistant
S. aureus (MRSA) among 26 Dutch farmers
living nearby a sentinel case of MRSA. Their
study demonstrated transmission of three
strains of MRSA from swine to pig farmers,
from pig farmers to their family members, and
from a hospitalized patient (the sentinel case)
to a nurse. Investigators in the United States
collected air samples via liquid impingers in a
swine CAFO and analyzed the samples for
viable isolates of antibiotic resistant bacteria
(Chapin et al. 2005). Enterococci, staphy-
lococci, and streptococci were analyzed for
resistance to erythromycin, clindamycin, vir-
giniamycin, tetracycline, and vancomycin.
None of the isolates were resistant to van-
comycin, which has never been approved for
use in livestock in the United States. In con-
trast, 98% of the isolates displayed resistance to
two or more of the other four antibiotics that
are commonly used as growth promotants in
swine. It is important to note that 37 of
124 isolates were resistant to all four of these
antibiotics (Chapin et al. 2005).
Sweden banned the use of antibiotics as
feed additives for growth promotion in 1985
(Swedish Veterinary Antimicrobial Resistance
Monitoring 2003). At that time Sweden used
20 metric tons of antibiotics for growth pro-
motion, 14 metric tons for group treatment
and 17 metric tons for treating individual sick
animals. In 2003, with no use allowed for
growth promotion, the amount of antibiotics
used for group treatment was 2 metric tons
(down from 14 metric tons), accompanied by a
decrease, rather than an increase, of individual
treatment use from 17 to 14 metric tons. This
demonstrates that the banning of growth pro-
motants did not lead to increased antibiotic use
in other categories. In Denmark, veterinary
researchers observed a 74% incidence of van-
comycin-resistant Enteroccocus faecium in
broiler chickens in 1995. Following a 1997
ban, the level of resistance fell to 2% by 2000
[Aarestrup et al. 2001; Danish Integrated
Antimicrobial Resistance Monitoring and
Research Programme (DANMAP) 2004]. In
the European Union, antibiotics also used for
human medicine were removed from animal
use in 1998, and all use of antibiotics as
growth promotants are being phased out by
2006 (Casewell et al. 2003). Currently,
Sweden and Denmark use less than 3 g of
antimicrobial agents per pig slaughtered,
whereas the United States uses 47 g (WHO
2003). The experience from the antibiotic bans
for broiler chickens demonstrates that the
decrease in production—in terms of decreased
feed efficiency—is small and is offset by the
savings in the cost of antimicrobial growth pro-
motants (Wegener 2003). According to the
WHO the increased cost to producers of pro-
ducing pigs without antibiotic growth pro-
motants is approximately 1% (WHO 2003)
and should be compared with the “likely
human health benefits to society of anti-
microbial growth promoter termination”
(WHO 2003).
Animal crowding, CAFO hygiene, tem-
perature and ventilation control, and stress all
have an impact on growth rate and the ability
of animals to resist disease. Research on the
use of other treatments such as probiotics and
vaccines holds promise. Probiotics involve the
deliberate use of harmless or even beneficial
colonizing organisms in food production. It
will be important to provide solutions for the
spread of antibiotic resistance via air, water,
and direct contact to CAFO workers. 
The WHO has called for human and vet-
erinary antimicrobial agents to be sold only
under prescription. They have also recom-
mended that all countries establish monitor-
ing programs for tracking use and resistance
to antimicrobials. The WHO has also called
for a rapid phase-out of the use of anti-
microbial growth promotants and the creation
of prudent use guidelines for veterinary care
(WHO 2003).
These practices are not limited to CAFOs.
However, it is widely recognized that anti-
biotic resistance can be staunched only if
every effort is made to limit inappropriate
use, both with humans and animals. 
Risk assessment. Microbial risk assess-
ment is an evolving discipline. Methods have
not been developed for estimating risks associ-
ated with more than one antibiotic and one
bacterium at a time. This approach does not
fully address the reality of the CAFO environ-
ment, where animals harbor multiple micro-
bial species that are exposed to multiple
antibiotics over the course of their lives.
Moreover, the existence of genetic multidrug
resistance determinants (e.g., plasmids carry-
ing genes coding for resistance to multiple
drugs) means that exposure to one antibiotic
may lead to increased reservoirs of multiple
other antibiotics as well. The fact that resis-
tance determinants may be transferred from
benign to pathogenic bacteria means that
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hypothetically could result in manifestation of
human disease only months to years later.
Reservoirs of resistance may develop relatively
rapidly and may not be completely reversible.
This suggests that reducing antibiotic usage
may not lead to equivalent reductions in resis-
tance among all bacteria of concern. Thus,
research should be concurrent with new public
policies to reduce antibiotic overuse and
ensure the protection of public health.
Vaccines. Development of vaccines could
reduce our reliance on antibiotics. The timing
of vaccine administration with respect to
maternal antibody levels in infants should be
studied. Human vaccine administration is
undergoing a revolution in anticipation of
mass vaccination strategies that may be
required to respond to a bioterrorism event.
These strategies may also be applicable to ani-
mals in veterinary disease prevention. Several
diseases afflicting livestock require further
research, including necrotic enteritis in poultry
(and the use of ionophores for coccidiostats);
pasteurella respiratory disease, and; swine
ileitis and swine dysentery, as well as diseases
of swine at weaning. 
Policy initiatives. A number of policy ini-
tiatives should be explored to establish consis-
tent and responsible operating practices as well
as to promote a shift in current thinking about
the value of antibiotic-free meat products.
These policies should address all levels of
CAFO operation, from the CAFO operators
themselves to local, state, and federal govern-
ments, veterinarians, agricultural and pharma-
ceutical industries, and the scientiﬁc research
community. To ensure sensible use of anti-
biotics, these issues should also be included in
the curricula of pharmacists, doctors, and
other medical providers. Furthermore, patients
must be suitably informed on the proper use
of antibiotics including safe disposal.
Producers and industry leaders can and
should be afforded the opportunity to assume a
leadership role in reducing antibiotic overuse.
This should be encouraged by identifying
existing producers—either domestic or interna-
tional—who are using no or reduced anti-
biotics and might assume demonstration
projects. Along with this, a mentoring system
could be created for the purpose of sharing
practices that have proven successful in estab-
lished CAFOs. For example, partners in
Sweden and Denmark—countries that have
experienced successful transitions to antibiotic-
free meat production—might be visited by
demonstration team producers, along with vet-
erinarians from the respective countries. Where
possible, Danish immigrants or American pro-
ducers of Danish descent might be paired with
Danish producers and veterinarians. These col-
laborative efforts would require travel funds
and the availability of antibiotic-free feed at
market prices for the duration of the project.
Costs should be tracked and producers reim-
bursed at the outset so that the interval of
adjustment to the new antibiotic-free regimen
is not burdensome.
Measures to improve the domestic market
for meat raised without routine antibiotics
should be sought to promote its vitality as a
marketable commodity in the United States.
At the same time, new overseas markets
should be identified, and these special U.S.
products heavily promoted as imports of
value and interest to the global economy. In
addition, product labeling could be made
more comprehensive and explicit so that con-
sumers can identify the product and make
selections according to their value system. In
fact, such improvements in labeling could be
an integral part of an overall quality assurance
program that drives the label. 
Infectious diseases. Influenza. Zoonoses
can be transmitted via water, air, consumption
or handling of meat products, or by direct
transmission from animals to humans. Recent
work by Myers and colleagues demonstrated
significantly elevated seroprevalence of anti-
bodies against H1N1 and H1N2 swine
influenza virus in occupationally exposed
adults compared with controls without swine
exposure (Myers et al. 2006). Odds ratios for
swine H1N1 infection were 35.3 for farmers,
17.8 for veterinarians, and 6.5 for meat proces-
sors. For H1N2 infection odds ratios were
13.8, 9.5, and 2.7, respectively (all signiﬁcant). 
The transmission of inﬂuenza is a continu-
ing concern. Whether it comes to humans from
avian species or swine, or from avian species via
swine, or perhaps from humans to swine,
strains of high transmissibility and pathogenic-
ity are likely to evolve and create another pan-
demic (Nature 2005; Webster and Hulse
2005). Recent outbreaks in Asia have shown
that transmission of infectious agents can arise
from small farms raising poultry in proximity to
domiciles and to other animals. However,
because CAFOs tend to concentrate large num-
bers of animals close together, they facilitate
rapid transmission and mixing of viruses. There
is a concern that increasing the numbers of
swine facilities adjacent to avian facilities could
further promote the evolution of the next pan-
demic. The swine industry has adopted a set of
guidelines to minimize these risks, including
a) entry of wild birds and rodents into CAFOs
should be limited; b) untreated surface water
that may have inﬂuenza viruses from aquatic
birds should not be used for washing facilities,
and c) waterfowl use of farm lagoons should be
minimized. Such prudent practices will mini-
mize risk. To avoid their becoming a mixing
vessel for swine or poultry viruses with human
viruses, CAFO workers should be immunized
against inﬂuenza routinely, preferably with the
killed vaccine. 
The best means to limit transmission of
inﬂuenza may already be inferred from avail-
able data. However, new questions may arise
as practices change. What distances should be
established between CAFOs housing swine
and those housing poultry? Is there a defin-
able, small farm size with minimal numbers
of animals that may be allowed? 
Surveillance programs should be insti-
tuted that maintain biosecurity in CAFOs
while maximizing the ability to identify and
respond to animal and zoonotic disease out-
breaks quickly and effectively.
Waterborne diseases. Concerns persist
about surface and groundwater contamination
that may have ecosystem and human health
impacts. Optimal siting and improved con-
struction practices of CAFOs would reduce
the potential for contamination. Escrow
accounts or insurance policies that would
ensure restoration of a vacated manure lagoon
to previous conditions should be imposed on
those considering building a CAFO. Solid
tanks or reservoirs rather than earthen waste
lagoons and municipal-style waste treatment
are needed to prevent manure contamination
of surface and groundwater with infectious
agents or antibiotic resistance genes.
Animal feed containing animal by-
products. Animal feed containing animal tis-
sues and by-products is a major concern, as
sporeforming bacteria likely will be present
even after processing. Included are feathers,
offal, carcasses, bone and blood meal, and ner-
vous system and brain tissue. Gram-negative
enterobacteria of the genus Salmonella will
multiply in the food when it is reintroduced at
the feeding unit. Salmonella can be transmitted
to humans through the slaughtering process.
Meat packing and CAFO workers are at
greater risk of acquiring infection because of
their close access to animals and feed. CAFOs
are so large and densely populated that when a
pathogen is introduced into the system, it is
difﬁcult to eliminate. Biosecurity should be rig-
orous, and extreme quality assurance systems
are warranted in these large operations.
Meat for human consumption. Pathogens
tend to be amplified in animals raised in
CAFOs and, thus, are more difﬁcult to elimi-
nate in meat packing processes. Research is
needed to develop better ways of controlling
pathogen growth in meat. Studies should inves-
tigate measures to control Salmonella cycling
within a CAFO. Improved hygiene and ventila-
tion may be sufﬁcient measures. Better controls
on the food processing environment are also
indicated. Organisms can amplify very effi-
ciently in a holding pen containing live animals.
Multidrug-resistant pathogens are of grave con-
cern and are more likely to arise in animal feed-
ing operations that rely on nontherapeutic
antibiotic use instead of enhanced hygiene, air
ﬁltration, biosecurity and disease surveillance.
CAFOs, infectious disease, and antibiotic resistance
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better means to reduce colonization of animals
and meat with Campylobacter, Salmonella,
Escherichia coli, and other organisms.
Workshop Recommendations
Priority research needs. 
•Discontinue nontherapeutic use in the
United States: The practice of feeding
antibiotics to animals as growth enhancers
should be phased out in the United States as
it has in the European Union and as called
for by the WHO, the IOM, and many sci-
entific and public health organizations.
Research studies should monitor the discon-
tinuation to ensure that the ban on anti-
biotic use for growth promotion is not
supplanted by increased therapeutic use.
• Surveillance programs: Coordinated nation-
wide surveillance programs (Aarestrup
2004) should be instituted to fully assess the
contribution of antibiotic use in livestock
production to the creation of ecological
reservoirs of resistance, or the transmission
of that resistance to humans.
• Strain identiﬁcation: Fingerprinting of iso-
lates of antibiotic-resistant bacteria and the
resistance elements should be conducted to
establish relationships among members of
the same species. Results should be used to
identify unknown sources of resistance and
to track changes in resistance profiles in
response to diminished antibiotic use.
• Influenza risk: Countries and states should
establish minimum separation distances for
swine and poultry facilities to reduce the
risk of inﬂuenza outbreaks.
•Manure storage and waste processing:
Livestock production facilities should incor-
porate solid tanks for manure storage and
municipal style waste treatment to limit
microbial and nutrient contamination of
surface and groundwater.
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